Show simple item record

dc.creatorGurwith, Marc
dc.creatorCondit, Richard C.
dc.creatorExcler, Jean-Louis
dc.creatorRobertson, James S.
dc.creatorKim, Denny
dc.creatorFast, Patricia E.
dc.creatorDrew, Stephen
dc.creatorWood, David
dc.creatorKlug, Bettina
dc.creatorWhelan, Mike
dc.creatorMoore, Tamala Mallett
dc.creatorKhuri-Bulos, Najwa
dc.creatorSmith, Emily R.
dc.creatorChen, Robert T
dc.creatorKochhar, Sonali
dc.date.accessioned2020-10-19T19:40:07Z
dc.date.available2020-10-19T19:40:07Z
dc.date.created2020
dc.identifier.issn0264-410Xspa
dc.identifier.otherhttps://doi.org/10.1016/j.vaccine.2020.09.042spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/14589
dc.description.abstractSeveral live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of live-attenuated viral vaccines. This will help key stakeholders assess potential safety issues and understand the benefit-risk of such vaccines. The standardized and structured assessment provided by the template would also help to contribute to improved communication and support public acceptance of licensed live-attenuated viral vaccines.spa
dc.format.extent6 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherVaccinespa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectBrighton Collaborationspa
dc.subjectCEPIspa
dc.subjectCOVID-19spa
dc.subjectVaccinespa
dc.subjectBenefit-riskspa
dc.subjectSafetyspa
dc.subjectLivespa
dc.subjectAttenuatedspa
dc.subjectViralspa
dc.subjectTemplatespa
dc.titleBrighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccinesspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.vaccine.2020.09.042spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record